The Long-term Safety of Hunterase (Idursulfase-beta) in Hunter Syndrome(Mucopolysaccharidosis II) Patients
Phase of Trial: Phase IV
Latest Information Update: 02 Jan 2018
Price : $35 *
At a glance
- Drugs Idursulfase (Primary)
- Indications Mucopolysaccharidosis II
- Focus Adverse reactions
- Sponsors GC Pharma
- 02 Jan 2018 According to a GC Pharma media release, Green Cross Corporation rebrands itself to GC Pharma.
- 19 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 03 Feb 2014 New trial record